Cypress Capital Group Reduces Holdings in Gilead Sciences, Inc.
DLRHX Fund | USD 27.37 0.02 0.07% |
Slightly above 61% of Delaware Healthcare's investor base is looking to short. The analysis of overall sentiment of trading Delaware Healthcare Fund mutual fund suggests that many investors are alarmed at this time. Delaware Healthcare's investing sentiment can be driven by a variety of factors including economic data, Delaware Healthcare's earnings reports, geopolitical events, and overall market trends.
Delaware |
Cypress Capital Group lowered its stake in shares of Gilead Sciences, Inc. by 1.2 percent during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 50,284 shares of the biopharmaceutical companys stock after selling 635 shares during the period. Cypress Capital Groups holdings in Gilead Sciences were worth 4,216,000 at the
Read at thelincolnianonline.com
Delaware Healthcare Fundamental Analysis
We analyze Delaware Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Delaware Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Delaware Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Delaware Healthcare is currently under evaluation in price to book among similar funds. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Delaware Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Delaware Healthcare mutual fund to make a market-neutral strategy. Peer analysis of Delaware Healthcare could also be used in its relative valuation, which is a method of valuing Delaware Healthcare by comparing valuation metrics with similar companies.
Peers
Delaware Healthcare Related Equities
OCLGX | Optimum Large | 0.78 | ||||
OCIEX | Optimum International | 0.63 | ||||
WASAX | Ivy Asset | 0.52 | ||||
OCFIX | Optimum Fixed | 0.34 | ||||
IMAAX | Ivy Apollo | 0.31 | ||||
WSGAX | Ivy Small | 0.28 | ||||
OCLVX | Optimum Large | 0.24 | ||||
OASGX | Optimum Small-mid | 0.16 | ||||
OASVX | Optimum Small-mid | 0.13 | ||||
OCSGX | Optimum Small-mid | 0.13 |
Other Information on Investing in Delaware Mutual Fund
Delaware Healthcare financial ratios help investors to determine whether Delaware Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delaware with respect to the benefits of owning Delaware Healthcare security.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |